Focal adhesion kinase (FAK) inhibition as a potential strategy for anticancer therapies

Drugs of the Future

Volumn 34, Issue 6, 2009, Pages 477-483

  Ma, Y ^a   Van De Water, B ^a   Le Devedec S ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4,5 BENZENETETRAAMINE; 2 [5 CHLORO 2 (2 METHOXY 4 MORPHOLINOANILINO) 4 PYRIMIDINYLAMINO] N METHYLBENZAMIDE; BENZENE DERIVATIVE; BOSUTINIB; CISPLATIN; DASATINIB; DIOLEOYLPHOSPHATIDYLCHOLINE; DOCETAXEL; FOCAL ADHESION KINASE; GEFITINIB; GENISTEIN; PF 04554878; PF 562271; PF 573228; PROTEIN TYROSINE KINASE INHIBITOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TAC 544; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; GLIOBLASTOMA; GLIOMA; HUMAN; LUNG CANCER; METASTASIS; NONHUMAN; OVARY TUMOR; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW;

EID: 76349098202     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2009.034.06.1386560     Document Type: Review

References (99)

1. Zaidel-Bar, R., Itzkovitz, S., Ma'ayan, A., Iyengar, R., Geiger, B. Functional atlas of the integrin adhesome. Nat Cell Biol 2007, 9(8): 858-67.
2. Cooper, L.A., Shen, T.-L., Guan, J.-L. Regulation of focal adhesion kinase by its amino-terminal domain through an autoinhibitory interaction. Mol Cell Biol 2003, 23(22): 8030-41.
3. Serrels, B., Serrels, A., Brunton, V.G. et al. Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nat Cell Biol 2007, 9(9): 1046-56.
4. Sawada, Y., Tamada, M., Dubin-Thaler, B.J. et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 2006, 127(5): 1015-26.
5. Lim, Y., Han, I., Jeon, J., Park, H., Bahk, Y.-Y., Oh, E.-S. Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. J Biol Chem 2004, 279(28): 29060-5.
6. Mitra, S.K., Hanson, D.A., Schlaepfer, D.D. Focal adhesion kinase: In command and control of cell motility. Nat Rev Mol Cell Biol 2005, 6(1): 56-68.
7. Arold, S.T., Hoellerer, M.K., Noble, M.E.M. The structural basis of localization and signaling by the focal adhesion targeting domain. Structure 2002, 10(3): 319-27.
8. Mitra, S.K., Mikolon, D., Molina, J.E. et al. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 2006, 25(44): 5969-84.
9. Jeon, J., Lee, H., Park, H. et al. Phosphorylation of focal adhesion kinase at tyrosine 407 negatively regulates Ras transformation of fibroblasts. Biochem Biophys Res Commun 2007, 364(4): 1062-6.
10. Lim, Y., Park, H., Jeon, J. et al. Focal adhesion kinase is negatively regulated by phosphorylation at tyrosine 407. J Biol Chem 2007, 282(14): 10398-404.
11. Ma, A., Richardson, A., Schaefer, E.M., Parsons, J.T. Serine phosphorylation of focal adhesion kinase in interphase and mitosis: a possible role in modulating binding to pl30(Cas). Mol Biol Cell 2001, 12(1): 1-12.
12. Parsons, J.T. Focal adhesion kinase: The first ten years. J Cell Sci 2003, 116(Pt. 8): 1409-16.
13. Park, A.Y.J., Shen, T.-L., Chien, S., Guan, J.-L. Role of focal adhesion kinase Ser-732 phosphorylation in centrosome function during mitosis. J Biol Chem 2009, 284(14): 9418-25.
14. Jacamo, R., Jiang, X., Lunn, J.A., Rozengurt, E. FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration. J Cell Physiol 2007, 210(2): 436-44.
15. van Nimwegen, M.J., Huigsloot, M., Camier, A., Tijdens, I.B., van de Water, B. Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol Pharmacol 2006, 70(4): 1330-9.
16. Zhao, J.H., Reiske, H., Guan, J.L. Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 1998, 143(7): 1997-2008.
17. Zhao, J., Pestell, R., Guan, J.L. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell 2001, 12(12): 4066-77.
18. Yamamoto, D., Sonoda, Y., Hasegawa, M., Funakoshi-Tago, M., Aizu-Yokota, E., Kasahara, T. FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways. Cell Signal 2003, 15(6): 575-83.
19. Lim, S.-T., Mikolon, D., Stupack, D.G., Schlaepfer, D.D. FERM control of FAK function: Implications for cancer therapy. Cell Cycle 2008, 7(15): 2306-14.
20. Golubovskaya, V.M., Cance, W.G. Focal adhesion kinase and p53 signaling in cancer cells. Int Rev Cytol 2007, 263: 103-53.
21. Lim, S.-T., Chen, X.L., Lim, Y. et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 2008, 29(1): 9-22.
22. Schlaepfer, D.D., Mitra, S.K. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004, 14(1): 92-101.
23. Wozniak, M.A., Modzelewska, K., Kwong, L., Keely, P.J. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004, 1692(2-3): 103-19.
24. Xu, Y., Benlimame, N., Su, J., He, Q., Alaoui-Jamali, M.A. Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells. Br J Cancer 2009, 100(4): 633-43.
25. Chan, K.T., Cortesio, C.L., Huttenlocher, A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol 2009, 185(2): 357-70.
26. Papusheva, E., Mello de Queiroz, F., Dalous, J. et al. Dynamic conformational changes in the FERM domain of FAK are involved in focal-adhesion behavior during cell spreading and motility. J Cell Sci 2009, 122(Pt. 5): 656-66.
27. Cohen, L.A., Guan, J.-L. Residues within the first subdomain of the FERM-like domain in focal adhesion kinase ore important in its regulation. J Biol Chem 2005, 280(9): 8197-207.
28. Chen, S.-Y., Chen, H.-C. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol Cell Biol 2006, 26(13): 5155-67.
29. Hauck, C.R., Sieg, D.J., Hsia, D.A. et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 2001, 61(19): 7079-90.
30. Hauck, C.R., Hsia, D.A., Puente, X.S., Cheresh, D.A., Schlaepfer, D.D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J 2002, 21(23): 6289-302.
31. Kornberg, L., Fleigel, J. The effects of inducible overexpression of FAK-related non-kinase (FRNK) on a transformed epithelial cell line. Anticancer Res 2003, 23(1A): 91-7.
32. Canel, M., Secades, P., Garzon-Arango, M. et al. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer 2008, 98(7): 1274-84.
33. Jones, C., Machado, J. Jr., Tolnay, M., Merlo, A. PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Res 2001, 61(15): 5688-91.
34. Johnson, T.R., Khandrika, L., Kumar, B. et al. Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer. Mol Cancer Res 2008, 6(10): 1639-48.
35. Owens, L.V., Xu, L., Craven, R.J. et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995, 55(13): 2752-5.
36. Golubovskaya, V.M., Kweh, F.A., Cance, W.G. Focal adhesion kinase and cancer. Histol Histopathol 2009, 24(4): 503-10.
37. Zhao, J., Guan, J.-L. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009, 28(1-2): 35-49.
38. Oktay, M.H., Oktay, K., Hamele-Bena, D., Buyuk, A., Koss, L.G. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol 2003, 34(3): 240-5.
39. Behmoaram, E., Bijian, K., Jie, S. et al. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Am J Pathol 2008, 173(5): 1540-50.
40. Cance, W.G., Harris, J.E., Iacocca, M.V. et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000, 6(6): 2417-23.
41. Garcia, S., Dates, J.-P., Charafe-Jauffret, E. et al. Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. Int J Oncol 2007, 31(1): 49-58.
42. Madan, R., Smolkin, M.B., Cocker, R., Fayyad, R., Oktay, M.H. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol 2006, 37(1): 9-15.
43. Lark, A.L., Livasy, C.A., Calvo, B. et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: Immunohistochemistry and real-time PCR analyses. Clin Cancer Res 2003, 9(1): 215-22.
44. Han, N.M., Fleming, R.Y., Curley, S.A., Gallick, G.E. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation. Ann Surg Oncol 1997, 4(3): 264-8.
45. Owens, L.V., Xu, L., Dent, C.A. et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996, 3(1): 100-5.
46. Rovin, J.D., Frierson, H.F. Jr., Ledinh, W., Parsons, J.T., Adams, R.B. Expression of focal adhesion kinase in normal and pathologic human prostate tissues. Prostate 2002, 53(2): 124-32.
47. Fujii, T., Koshikawa, K., Nomoto, S. et al. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol 2004, 41(1): 104-11.
48. Itoh, S., Maeda, T., Shimada, M. et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 2004, 10(8): 2812-7.
49. Hess, A.R., Postovit, L.-M., Margaryan, N.V. et al. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res 2005, 65(21): 9851-60.
50. Sood, A.K., Coffin, J.E., Schneider, G.B. et al. Biological significance of focal adhesion kinase in ovarian cancer: Role in migration and invasion. Am J Pathol 2004, 165(4): 1087-95.
51. Agochiya, M., Brunton, V.C., Owens, D.W. et al. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 1999, 18(41): 5646-53.
52. Gabarra-Niecko, V., Schaller, M.D., Dunty, J.M. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 2003, 22(4): 359-74.
53. Weiner, T.M., Liu, E.T., Craven, R.J., Cance, W.G. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993, 342(8878): 1024-5.
54. Lark, A.L., Livasy, C.A., Dressier, L. et al. High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol 2005, 18(10): 1289-94.
55. Peng, X., Wu, X., Druso, J.E. et al. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci USA 2008, 105(18): 6638-43.
56. McLean, G.W., Komiyama, N.H., Serrels, B. et al. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 2004, 18(24): 2998-3003.
57. Weis, S.M., Lim, S.-T., Lutu-Fuga, K.M. et al. Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. J Cell Biol 2008, 181(1): 43-50.
58. Lahlou, H., Sanguin-Gendreau, V., Zuo, D. et al. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 2007, 104(51): 20302-7.
59. Nagy, T., Wei, H., Shen, T.-L. et al. Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. J Biol Chem 2007, 282(43): 31766-76.
60. Provenzano, P.P., Inman, D.R., Eliceiri, K.W., Beggs, H.E., Keely, P.J. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol 2008, 173(5): 1551-65.
61. Luo, M., Fan, H., Nagy, T. et al. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res 2009, 69(2): 466-74.
62. Abbi, S., Ueda, H., Zheng, C. et al. Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 2002, 13(9): 3178-91.
63. Ueda, H., Abbi, S., Zheng, C., Guan, J.L. Suppression of Pyk2 kinase and cellular activities by FIP200. J Cell Biol 2000, 149(2): 423-30.
64. Melkoumian, Z.K., Peng, X., Gan, B., Wu, X., Guan, J.-L. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 2005, 65(15): 6676-84.
65. Chano, T., Kontani, K., Teramoto, K., Okabe, H., Ikegawa, S. Truncating mutations of RB1CC1 in human breast cancer. Nat Genet 2002, 31(3): 285-8.
66. Wang, D., Grammer, J.R., Cobbs, C.S. et al. p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo. J Cell Sci 2000, 113(Pt. 23): 4221-30.
67. Abdel-Ghany, M., Cheng, H.-C., Elble, R.C., Pauli, B.U. Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J Biol Chem 2002, 277(37): 34391-400.
68. van Nimwegen, M.J., Verkoeijen, S., van Buren, L., Burg, D., van de Water, B. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 2005, 65(11): 4698-706.
69. Mitra, S.K., Schlaepfer, D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006, 18(5): 516-23.
70. Mitra, S.K., Lim, S.T., Chi, A., Schlaepfer, D.D. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene 2006, 25(32): 4429-40.
71. Benlimame, N., He, Q., Jie, S. et al. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol 2005, 171(3): 505-16.
72. Pylayeva, Y., Gillen, K.M., Gerald, W., Beggs, H.E., Reichardt, L.F., Giancotti, F.G. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009, 119(2): 252-66.
73. Han, E.K.-H., McGonigal, T., Wang, J., Giranda, V.L., Luo, Y. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs. Anticancer Res 2004, 24(6): 3899-905.
74. Jiang, X., Jacamo, R., Zhukova, E., Sinnett-Smith, J., Rozengurt, E. RNA interference reveals a differential role of FAK and Pyk2 in cell migration, leading edge formation and increase in focal adhesions induced by LPA in intestinal epithelial cells. J Cell Physiol 2006, 207(3): 816-28.
75. Tsutsumi, K., Kasaoka, T., Park, H.-M., Nishiyama, H., Nakajima, M., Honda, T. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase. Int J Oncol 2008, 33(1): 215-24.
76. Lipinski, C.A., Tran, N.L., Viso, C. et al. Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts. J Neurooncol 2008, 90(2): 181-9.
77. Li, S., Dong, W., Zong, Y. et al. Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol Ther 2007, 15(3): 515-23.
78. Haider, J., Kamat, A.A., Landen, C.N. Jr. et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006, 12(16): 4916-24.
79. Shintani, S., Li, C., Mihara, M., Nakashiro, K.-I., Hamakawa, H. Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. Cancer Lett 2003, 201(2): 149-55.
80. Liu, Y., Kyle, E., Lieberman, R., Crowell, J., Kellof, C., Bergan, R.C. Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation. Clin Exp Metastasis 2000, 18(3): 203-12.
81. Matsumoto, K., Nakamura, T., Kramer, R.H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994, 269(50): 31807-13.
82. Vultur, A., Buettner, R., Kowolik, C. et al. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther 2008, 7(5): 1185-94.
83. Johnson, F.M., Saigal, B., Talpaz, M., Donato, N.J. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 2005, 11(19, Pt. 1): 6924-32.
84. Shi, Q., Hjelmeland, A.B., Keir, S.T. et al. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog 2007, 46(6): 488-96.
85. Slack-Davis, J.K., Martin, K.H., Tilghman, R.W. et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007, 282(20): 14845-52.
86. Roberts, W.G., Ung, E., Whalen, P. et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 2008, 68(6): 1935-44.
87. Bagi, C.M., Roberts, C.W., Andresen, C.J. Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: Implications for bone metastases. Cancer 2008, 112(10): 2313-21.
88. Siu L.L., Burris H.A., Mileshkin L.R. et al. A phase I clinical, pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of PF-00562271 targeting focal adhesion kinase (FAK) in patients (pts) with advanced solid tumors. J Clin Oncol [44th Annu Meet Am Soc Clin Oncol) (ASCO) (May 31-June 3, Chicago) 2008] 2008, 26(15, Suppl.): Abst 3534.
89. Haider, J., Lin, Y.C., Merritt, W.M. et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res 2007, 67(22): 10976-83.
90. Watanabe, N., Takaoka, M., Sakurama, K. et al. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. Clin Cancer Res 2008, 14(14): 4631-9.
91. Lietha, D., Eck, M.J. Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. PLoS ONE 2008, 3(11): e3800.
92. Sakurama, K., Noma, K., Takaoka, M. et al. Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-reslstant gastrointestinal stromal tumor. Mol Cancer Ther 2009, 8(1): 127-34.
93. Chatzizacharias, N.A., Kouraklis, G.P., Theocharis, S.E. Focal adhesion kinase: A promising target for anticancer therapy. Expert Opin Ther Targets 2007, 11(10): 1315-28.
94. Han, E.K.-H., McGonigal, T. Role of focal adhesion kinase in human cancer: A potential target for drug discovery. Anticancer Agents Med Chem 2007, 7(6): 681-4.
95. van Nimwegen, M.J., van de Water, B. Focal adhesion kinase: A potential target in cancer therapy. Biochem Pharmacol 2007, 73(5): 597-609.
96. Parsons, J.T., Slack-Davis, J., Tilghman, R., Roberts, W.G. Focal adhesion kinase: Targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 2008, 14(3): 627-32.
97. Li, S., Hua, Z.-C. FAK expression regulation and therapeutic potential. Adv Cancer Res 2008, 101:45-61.
98. Golubovskaya, V.M., Virnig, C., Cance, W.G. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR. Mol Carcinog 2008, 47(3): 222-34.
99. Golubovskaya, V.M., Nyberg, C., Zheng, M. et al. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J Med Chem 2008, 51(23): 7405-16.